AMEX : APUS

Apimeds Pharmaceuticals US, Inc

$0.6705 USD

$0.02 (2.37%)

Volume
11.98K
Average Volume
189.45K
Market Capitalization
$843.22K
P/E Ratio
-0.11
Dividend Yield
0.00%
Price Target
Year High
$40.31
Year Low
$0.62
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.90
Insider Activity Summary (Last 12 Months)
Insiders Buying

12

Insiders Selling

0

Amount of Insider Selling

-$

APUS Insider Buying/Selling by Quarter
APUS Insider Trading History
Insider Name Title Date Transaction Cost Filing Date
Inscobee Inc. 10 percent owner: 2024-05-12 0 2025-11-21
Weintraub Bennett director 2025-11-11 A-Award 2.67 2025-11-13
Yoon Hankil director 2025-11-11 A-Award 2.67 2025-11-13
Koo Jakap director 2025-11-11 A-Award 2.67 2025-11-13
O'DONNELL CAROL A director 2025-11-11 A-Award 2.67 2025-11-13
Kogan Elona director 2025-11-11 A-Award 2.67 2025-11-13
Kogan Elona director 2025-10-15 A-Award 1.92 2025-10-24
O'DONNELL CAROL A director 2025-10-15 A-Award 1.92 2025-10-21
Koo Jakap director 2025-10-15 A-Award 1.92 2025-10-17
Weintraub Bennett director 2025-10-15 A-Award 1.92 2025-10-17
Kim Christopher director, officer: Chairman and CMO 2025-10-15 A-Award 1.92 2025-10-17
Yoon Hankil director 2025-10-15 A-Award 1.92 2025-10-17
Emerson Erik C. director, officer: Chief Executive Officer 2025-10-15 A-Award 1.92 2025-10-17